Forest plot of GLP-1 receptor agonists versus comparators on the risk of Pulmonary hypertension
Gupta YK, Ramachandran SS
GLP-1 pills and injections have the same side effects
The medications work by reducing appetite and improving satiety, making it easier to eat less, but patients who view them as solutions requiring zero behavior change typically experience less significant outcomes than trial data suggests
But there have also been troubling side effects reported
We excluded patients with cirrhotic liver, history of gall bladder, biliary disorders, pancreatic diseases, interrupted use of GLP-1RAs throughout the study period, and patients used other drugs with potential effects on the motility of biliary tracts such as cholecystokinin, motilin hormone, cholinomimetic agents like prostigmine, erythromycin, cisapride, cholystyramine, intravenous aminoacids, cholinergic agents like atropine, somatostatin, and progesterone, trimebutine, loperamide and ondansetron
